// App-Quantinova.ai

3286 : Targeting mir101/ EZH2/NFkb axis by FGFR1 inhibitor in mantle cell lymphoma

Researchers

Presenter

  • Lalit Sehgal

Principal Investigators

  • Neeraj Jain

  • Tamer Khashab

  • xin wang

  • Sattva Neelapu

  • Felipe Samaniego

Medical Centers

  • UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER, HOUSTON, TX.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non-Hodgkin's Lymphoma

  • Mantle cell lymphoma

  • Hodgkin's Lymphoma

  • B cell lymphomas

  • Non‐Hodgkin Lymphoma

  • Lymphomas

  • Solid malignancies

Biomarkers

  • Basic fibroblast growth factor

  • Cyclin D1

  • Enhancer of zeste homolog 2

  • Fibroblast growth factor receptor 1

  • Interleukin 6

Drug/Treatment

  • EZH2

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved